{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:28:14Z","timestamp":1749313694541},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Worldwide, a final crossmatch is the gold standard for determining compatibility between patient and donor before solid organ transplantation and preventing hyperacute rejection. In the absence of autoantibodies, an incompatible crossmatch in a sensitized patient is attributed to mismatched donor HLA. However, current physical crossmatch methods cannot distinguish reactivity to HLA from other clinically irrelevant cell surface targets nor the class of HLA if it is the target. Result interpretation is difficult or impossible when autoantibodies, alloantibodies, or therapeutic antibodies coexist.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Herein, we describe a unique donor-specific flow crossmatch (DSA-FXM) that distinguishes HLA class I or II donor-specific antibody bound to HLA antigens on the donor cell surface in their native conformation that is not impacted by rituximab, anti-thymocyte globulin (after absorption), or autoantibodies. It is HLA specific.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>We compared the results of single-antigen antibody testing, autoreactive and alloreactive flow cytometry crossmatches (FXM) using traditional FXM and our DSA-FXM method from 94 patients (enriched for auto+\/allo+ pairs; n = 64) against 110 donors (338 tests) and show that, in our cohort, positive traditional FXM results are not directed to donor HLA 60.25% of the time and negative traditional FXM results are missing HLA donor-specific antibody 36.2% of the time based on the DSA-FXM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>We demonstrate that the DSA-FXM is able to define categorically distinct and clinically important HLA antibody profiles in half the time required for the standard FXM, potentially shortening cold ischemia time and providing clinicians with unambiguous essential information regarding HLA compatibility when time is critical.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002900","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T16:41:37Z","timestamp":1565023297000},"page":"813-822","source":"Crossref","is-referenced-by-count":4,"title":["DSA-FXM: Accelerated Donor-specific Flow Crossmatch Discriminating Class I and II Antibody Specifically and Only to Donor HLA for Determining True Incompatibility"],"prefix":"10.1097","volume":"104","author":[{"given":"Ge","family":"Chen","sequence":"first","affiliation":[{"name":"Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Lin","sequence":"additional","affiliation":[{"name":"Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolly B.","family":"Tyan","sequence":"additional","affiliation":[{"name":"Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA."},{"name":"Department of Pathology, Stanford University School of Medicine, Palo Alto, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trim.2013.05.001","article-title":"Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.","volume":"28","author":"Fidler","year":"2013","journal-title":"Transpl Immunol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure.","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","article-title":"Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome.","volume":"11","author":"Cantarovich","year":"2011","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/TP.0000000000000672","article-title":"Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing.","volume":"99","author":"S\u00fcsal","year":"2015","journal-title":"Transplantation"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/204998b0","article-title":"Microdroplet assay of human serum cytotoxins.","volume":"204","author":"Terasaki","year":"1964","journal-title":"Nature"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation.","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R13-20231002","first-page":"1939","article-title":"Flow cytometry analysis: a high technology cross-match technique facilitating transplantation.","volume":"15","author":"Garovoy","year":"1983","journal-title":"Transplant Proc"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","article-title":"Novel C1Q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00007890-200102150-00015","article-title":"Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.","volume":"71","author":"Vaidya","year":"2001","journal-title":"Transplantation"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.","volume":"3","author":"Gebel","year":"2003","journal-title":"Am J Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humimm.2017.10.020","article-title":"Rapid optimized flow cytometric crossmatch (FCXM) assays: the Halifax and Halifaster protocols.","volume":"79","author":"Liwski","year":"2018","journal-title":"Hum Immunol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00007890-196811000-00006","article-title":"Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.","volume":"6","author":"Mittal","year":"1968","journal-title":"Transplantation"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00007890-197802000-00014","article-title":"B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes.","volume":"25","author":"Pellegrino","year":"1978","journal-title":"Transplantation"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.humimm.2015.01.049","article-title":"LBP17: a scientific myth: there is more HLA class I on B cells than on T cells.","volume":"76","author":"Sequeira","year":"2015","journal-title":"Hum Immunol"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.humimm.2011.01.005","article-title":"Impact of pronase on flow cytometric crossmatch outcome.","volume":"72","author":"Hetrick","year":"2011","journal-title":"Hum Immunol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody-mediated rejection of cardiac transplants.","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"S1","key":"R23-20231002","first-page":"95","article-title":"Novel crossmatch testing of organ donors and recipients by ELISA: clinical relevance of test results.","volume":"44","author":"Monteiro","year":"1995","journal-title":"Hum Immunol"},{"issue":"Suppl 1","key":"R24-20231002","first-page":"16","article-title":"Novel crossmatch testing of organ donors and recipients by ELISA: results of a blinded multicenter study.","volume":"44","author":"Buelow","year":"1995","journal-title":"Hum Immunol"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0039.2008.01032.x","article-title":"Luminex donor-specific crossmatches.","volume":"71","author":"Billen","year":"2008","journal-title":"Tissue Antigens"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00007890-199812270-00042","article-title":"Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies.","volume":"66","author":"Susskind","year":"1998","journal-title":"Transplantation"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/01621459.1978.10481567","article-title":"Small-sample comparisons of exact levels for chi-squared goodness-of-fit statistics.","volume":"73","author":"Larntz","year":"1978","journal-title":"J Am Stat Assoc"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/00007890-199560120-00037","article-title":"Soluble HLA antigens and ELISA\u2013a new technology for crossmatch testing.","volume":"60","author":"Buelow","year":"1995","journal-title":"Transplantation"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.coi.2008.07.008","article-title":"Post-transplantation antibody monitoring and HLA antibody epitope identification.","volume":"20","author":"Cai","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males.","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MOT.0b013e328331c169","article-title":"Utility of the virtual crossmatch in solid organ transplantation.","volume":"14","author":"Amico","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trim.2011.05.007","article-title":"Positive virtual crossmatch with negative flow crossmatch results in two cases.","volume":"25","author":"Jacob","year":"2011","journal-title":"Transpl Immunol"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.humimm.2011.02.012","article-title":"Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?","volume":"72","author":"Pereira","year":"2011","journal-title":"Hum Immunol"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.humimm.2011.08.001","article-title":"Heart transplantation with donor-specific antibodies directed toward denatured HLA-A*02:01: a case report.","volume":"72","author":"Poli","year":"2011","journal-title":"Hum Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:08:05Z","timestamp":1696223285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002900","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}